Lifecare AS has strengthened its Board of Directors at its extraordinary general meeting. In line with the recommendation from the company's nomination committee and a proposal from the company's shareholder Teigland Eiendom AS, the new board members are: As deputy chairman: Morten Foros Krohnstad, Bergen, Norway. Kronstad is a partner in the law firm Schjødt and has extensive experience as a business lawyer with main areas of work in M&A and corporate, including corporate litigation. He serves on a number of boards as chairman and board member in Norwegian listed and un-listed companies. As a board member: Prof. Dr. Lutz Heinemann, Düsseldorf, Germany. Heinemann has a broad academic background with a special focus on research and development in insulin pharmacology and diabetes technology. Heinemann established the Profil Institute for Metabolic Research in Neuss, Germany in 2009 and since 2011 he has been Managing Editor of The Journal of Diabetes Science and Technology. As board member: Bo Petersson, Copenhagen, Denmark. Peterson holds a Ph.D. in Chemistry from The Technical University of Denmark. Peterson has over 20 years of work experience in developing diabetes technology products, most recently as Head of Diabetes Care at Cambridge Consultants, Cambridge, UK. Petersson is also engaged as Chief Scientific Officer in RSP Systems A /S, Copenhagen, Denmark. In addition to the newly elected board members, the board consists of board chairman Christian Hysing-Dahl and board member Trine Teigland.